{"jsonapi":{"version":"1.0"},"data":{"type":"recalls","id":"0d35a8db93efb5a696e10f55aa627262603ae57f7c6b57a6ba167fad7b945e69","attributes":{"feedName":"medwatch","feedSource":"medwatch","title":"Liquid-filled Intragastric Balloons by Apollo Endosurgery and ReShape Lifesciences: Letter to Health Care Providers - New Labeling About Potential Risks","description":"FDA has approved new labeling for the Orbera and ReShape balloon systems with more information about possible death associated with the use of these devices.","link":"https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm609761.htm","publicationDate":"2018-06-04T04:00:00.000Z","state":"sent","affected":[],"allergens":[],"audience":["professionals"],"categories":["medical"],"contaminants":[],"distribution":["AL","AK","AZ","AR","CA","CO","CT","DE","DC","FL","GA","HI","ID","IL","IN","IA","KS","KY","LA","ME","MD","MA","MI","MN","MS","MO","MT","NE","NV","NH","NJ","NM","NY","NC","ND","OH","OK","OR","PA","RI","SC","SD","TN","TX","UT","VT","VA","WA","WV","WI","WY"],"risk":"none","token":"5d9e68818b079e002a25098a"}}}